Rapport Therapeutics (RAPP) EPS (Weighted Average and Diluted) (2023 - 2026)
Rapport Therapeutics (RAPP) reported EPS (Weighted Average and Diluted) of -$0.42 for Q1 2026, up 38.24% year-over-year from -$0.3 in Q1 2025, and up 40.85% quarter-over-quarter from -$0.71 in Q4 2025.
Rapport Therapeutics (RAPP) EPS (Weighted Average and Diluted) (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.42 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.42, up 38.24% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.59 (up 13.67% YoY), and the FY2025 annual result was -$2.86, up 24.34% from the prior year.
- EPS (Weighted Average and Diluted) climbed to -$0.42 in Q1 2026 per RAPP's latest filing, from -$0.71 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$0.12 in Q4 2024 and troughed at -$11.07 in Q1 2024.
- A 4-year average of -$2.93 and a median of -$0.73 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) surged 98.57% in 2024, then slumped 491.67% in 2025.
- A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$8.38 in 2023, then soared by 98.57% to -$0.12 in 2024, then tumbled by 491.67% to -$0.71 in 2025, then jumped by 40.85% to -$0.42 in 2026.
- Business Quant data shows RAPP's EPS (Weighted Average and Diluted) at -$0.42 in Q1 2026, -$0.71 in Q4 2025, and -$0.71 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 0.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.61 |
| 10 | Rapport Therapeutics | 1.66 Bn | 1.66 Bn | - | -0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.42 |
| Dec 31, 2025 | -0.71 |
| Sep 30, 2025 | -0.71 |
| Jun 30, 2025 | -0.75 |
| Mar 31, 2025 | -0.68 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | -0.50 |
| Jun 30, 2024 | -1.70 |
| Mar 31, 2024 | -11.07 |
| Dec 31, 2023 | -8.38 |
| Sep 30, 2023 | -5.70 |
| Jun 30, 2023 | -4.45 |